US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Bionano Genomics Inc (BNGO)
Bionano Genomics Inc (BNGO) ニュース

BNGO

Bionano Genomics (BNGO)

Bionano Genomics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BNGO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	21 : 00	GlobeNewswire Inc.	Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	21 : 00	GlobeNewswire Inc.	Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	06 : 27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	05 : 09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/09	05 : 01	GlobeNewswire Inc.	Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/01	21 : 00	GlobeNewswire Inc.	Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/05/01	05 : 05	GlobeNewswire Inc.	Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/24	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/17	21 : 00	GlobeNewswire Inc.	Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/11	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/05	02 : 44	GlobeNewswire Inc.	Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/03	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	NASDAQ:BNGO	Bionano Genomics Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/19	21 : 00	GlobeNewswire Inc.	Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/07	22 : 00	GlobeNewswire Inc.	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	07 : 26	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	06 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/03/06	06 : 01	GlobeNewswire Inc.	Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/29	22 : 00	GlobeNewswire Inc.	Bionano to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22 : 01	GlobeNewswire Inc.	Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/28	22 : 00	GlobeNewswire Inc.	Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway	NASDAQ:BNGO	Bionano Genomics Inc
2024/02/22	22 : 00	GlobeNewswire Inc.	American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/31	22 : 00	GlobeNewswire Inc.	Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:BNGO	Bionano Genomics Inc
2024/01/30	22 : 00	GlobeNewswire Inc.	Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS	NASDAQ:BNGO	Bionano Genomics Inc

Showing the most relevant articles for your search:NASDAQ:BNGO

1 2 3 4 5 6 7 8 9 10 次へ >>

Red White & Bloom Brands

Wheaton Precious Metals

Rainbow New Deal Enterpr...

Litman Gregory F

Mass Mutual Equity Oppor...

Pofid Dao Token

Vector Acquisition

Wisdom Tree Autom Innova...

BNPP SRIC5 INAV

OSSIAM OP7H INAV

Amaya Global (CE)

Haranga Resources

New Zealand Windfarms (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約